KOIL Energy announces award of a significant contract
HOUSTON, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Koil Energy Solutions, Inc. (OTCQB: KLNG), an international specialist in subsea equipment and services, today announces the award of a significant contract, which includes control equipment for a subsea isolation valve system. The purpose of the system is to protect the offshore platform and its personnel from the unintended release of hydrocarbons from subsea wells. The contract encompasses the engineering, procurement, and manufacturing of KOIL's robust and well-proven technical solution for Subsea Safety Control Systems.
"This contract highlights our team's achievement in creating integrated solutions," said Erik Wiik, CEO of KOIL Energy. "We are honored to have earned our customers’ trust to deliver equipment that will play a vital role in enhancing the safety of their offshore facility."
KOIL Energy will perform engineering and procurement activities during 2025 followed by manufacturing at its state-of-the-art production facility in Houston, Texas in the first half of 2026. A services contract for the installation and testing will be awarded later.
About KOIL (www.koilenergy.com)
KOIL Energy is a leading energy services company offering subsea equipment and support services to the world's energy and offshore industries. We provide innovative solutions to complex customer challenges presented between the production facility and the energy source. Our core services and technological solutions include distribution system installation support and engineering services, umbilical terminations, loose-tube steel flying leads, and related services. Additionally, KOIL Energy's experienced team can support subsea engineering, manufacturing, installation, commissioning, and maintenance projects located anywhere in the world.
Investor Relations:
[email protected]
281-862-2201
Source: Koil Energy Solutions, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Orum Therapeutics Announces U.S. FDA Clearance of an IND Application for ORM-1153, a Novel CD123-GSPT1 Degrader-Antibody Conjugate
- Bitcoin Targets $77K After a Short Squeeze as XRP Jumps 20% and Apeing Enters the Best Upcoming Crypto Presale Race
- Alibaba Group Announced Proposed Placing of New Shares in Hong Kong
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share